Clinical Research Directory
Browse clinical research sites, groups, and studies.
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
Sponsor: Biotheus Inc.
Summary
PM8002 is a bispecific antibody targeting PD-L1 and VEGF. This study will evaluate the efficacy and safety of PM8002 in combination with Paclitaxel as second-line treatment for SCLC
Official title: A Multicenter, Open-lable, Randomized Phase III Study of PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
404
Start Date
2024-11-13
Completion Date
2028-12-25
Last Updated
2024-12-19
Healthy Volunteers
No
Conditions
Interventions
PM8002
Following a predefined dose and date.
Paclitaxel
175mg/m2 via IV infusion on Day 1 Q3W
Topotecan
1.25mg/m2/day via IV infusion on Days 1-5 Q3W
Locations (45)
Affiliated Hospital of Nantong University
Nantong, Jiangsu, China
Jilin Cancer Hospital
Changchun, Jilin, China
The First Affiliated Hospital Of Ningbo University
Ningbo, Zhejiang, China
Binzhou Medical University Hospital
Binzhou, China
Hunan Cancer Hospital
Changsha, China
Sichuan Cancer Hospital
Chengdu, China
First People's Hospital of Chenzhou
Chenzhou, China
The First Affiliated Hospital of Army Medical University
Chongqing, China
The Second Hospital of Dalian Medical University
Dalian, China
The First People's Hospital of Foshan
Foshan, China
Fujian Cancer Hospital
Fuzhou, China
The Affiliated Hospital Of Guilin Medical University
Guilin, China
Zhejiang Cancer Hospital
Hangzhou, China
Harbin Medical University Cancer Hospital
Harbin, China
Anhui Province Hospital
Hefei, China
Shandong Cancer Institute
Jinan, China
Jingzhou First People's Hospital
Jingzhou, China
Affiliated Hospital of Jining Medical University
Jining, China
Yunnan Cancer Hospital
Kunming, China
Liuzhou People's Hospital
Liuchow, China
The First Affiliated Hospital of Henan University of Science & Technology
Luoyang, China
Meizhou People's Hospital
Meizhou, China
Mianyang Central Hospital
Mianyang, China
Jiangxi Cancer Hospital
Nanchang, China
The First Affiliated Hospital of Nanchang University
Nanchang, China
Nanchong Central Hospital
Nanchong, China
Jiangsu Province Hospital
Nanjing, China
Nanjing Drum-Tower Hospital
Nanjing, China
Guangxi Medical University Cancer Hospital
Nanning, China
Nanyang Central Hospital
Nanyang, China
Qujing NO.1 Hospital
Qujing, China
The Fourth Hospital of Hebei Medical University
Shijia Zhuang, China
Taizhou Enze Medical Center (group)
Taizhou, China
Weifang NO.2 People's Hospital
Weifang, China
Weihai Municipal Hospital
Weihai, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
Zhongnan Hospital Of Wuhan University
Wuhan, China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
Xiangyang Central Hospital
Xiangyang, China
Xuzhou Central Hospital
Xuzhou, China
The Second People's Hospital Of Yibin
Yibin, China
Yongzhou Central Hospital
Yongzhou, China
Yuncheng City Center Hospital
Yuncheng, China
Zhangzhou Municipal Hospital of Fujian Province
Zhangzhou, China
Zhoukou Central Hospital
Zhoukou, China